EUVIMEDEUVIMED entdecken
Crossref

Mitochondria-enriched BMSC exosomes restore microglia–neuron cross-talk in Parkinson’s disease via PINK1/parkin and PI3K/Akt/mTOR pathways

Shanshan Shi, Ruyue Liu, Chang Liu, Yuyao Chen, Yujun Pan, Chunyan Wang

Brain Research · 2026

DOI: 10.1016/j.brainres.2026.150487 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Brain Research, 2026. Verfasst von Shanshan Shi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, The First Affiliated Hospital of Harbin Medical University, Harbin, China. Hauptthemen laut MEDLINE: Exosomes, Microglia, Mitochondria, Parkinson Disease. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: Postdoctoral Foundation of Hei Long Jiang Province, National Natural Science Foundation of China, China Primary Health Care Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Mitochondrial dysfunction and neuroinflammation drive dopaminergic neuron loss in Parkinson's disease (PD). While BMSC-derived small extracellular vesicles (BMSC-Exo) are neuroprotective, their ability to repair mitochondrial deficits is limited. We engineered mitochondrial-enriched sEVs (Exo-Mito) to evaluate their effects on microglia-neuron interactions in a PD-relevant model. METHODS: BMSC-Exo-Mito were characterized via TEM, NTA, and immunoblotting. Their therapeutic efficacy was assessed using an MPP + -induced BV2/SH-SY5Y transwell co-culture model. Assessments included ROS levels, mitochondrial membrane potential, ATP quantification, mitophagy flux, and signaling pathway analysis. RESULTS: Exo-Mito significantly restored mitochondrial homeostasis by reducing ROS, preserving membrane potential, and increasing ATP production. Mechanistically, Exo-Mito enhanced PINK1/Parkin-dependent mitophagy and PGC-1alpha/TFAM-mediated biogenesis. In BV2 microglia, Exo-Mito suppressed the NF-kappaB/NLRP3 axis, reduced proinflammatory cytokines, and promoted M2 polarization. In SH-SY5Y cells with dopaminergic phenotype, Exo-Mito was associated with reactivated PI3K/Akt/mTOR signaling, preserved tyrosine hydroxylase expression, and inhibited apoptosis. Functionally, Exo-Mito improved SH-SY5Y cell and restored microglial migratory capacity, showing superior efficacy to unmodified BMSC-Exo. CONCLUSION: Mitochondria-enriched BMSC sEVs protect SH-SY5Y cells by coordinating mitochondrial quality control and modulating neuroinflammation. These findings support Exo-Mito as a promising cell-free therapeutic strategy for Parkinson's disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ExosomesMicrogliaMitochondriaParkinson DiseaseTOR Serine-Threonine KinasesPTEN-Induced Putative KinaseProto-Oncogene Proteins c-aktPhosphatidylinositol 3-KinasesProtein KinasesUbiquitin-Protein LigasesHumansAnimalsSignal TransductionDopaminergic NeuronsMiceMitophagyMesenchymal Stem CellsNeuronsMembrane Potential, MitochondrialCoculture Techniques

Stichwörter der Autor:innen

Mesenchymal stem cellsMitochondriaMitophagyNeuroinflammationPI3K/Akt/mTORParkinson’s diseaseSmall extracellular vesicles

Substanzen

TOR Serine-Threonine KinasesPTEN-Induced Putative KinaseProto-Oncogene Proteins c-aktPhosphatidylinositol 3-KinasesProtein KinasesUbiquitin-Protein Ligasesparkin protein

Autor:innen und Institutionen

  • Department of Neurology, The First Affiliated Hospital of Harbin Medical University, Harbin, China.
  • Department of Neurology, The First Affiliated Hospital of Harbin Medical University, Harbin, China. Electronic address: yujunpan@ems.hrbmu.edu.cn.
  • Department of Neurology, The First Affiliated Hospital of Harbin Medical University, Harbin, China. Electronic address: wcysjnk@hrbmu.edu.cn.

Förderung

  • Postdoctoral Foundation of Hei Long Jiang Province
  • National Natural Science Foundation of China
  • China Primary Health Care Foundation

Zitieren

APA

Shi, S., Liu, R., Liu, C., Chen, Y., Pan, Y., & Wang, C. (2026). Mitochondria-enriched BMSC exosomes restore microglia–neuron cross-talk in Parkinson’s disease via PINK1/parkin and PI3K/Akt/mTOR pathways. Brain Research. https://doi.org/10.1016/j.brainres.2026.150487

Vancouver

Shi S, Liu R, Liu C, Chen Y, Pan Y, Wang C. Mitochondria-enriched BMSC exosomes restore microglia–neuron cross-talk in Parkinson’s disease via PINK1/parkin and PI3K/Akt/mTOR pathways. Brain Research. 2026. doi:10.1016/j.brainres.2026.150487

BibTeX
@article{Shi2026,
  author = {Shi, Shanshan and Liu, Ruyue and Liu, Chang and Chen, Yuyao and Pan, Yujun and Wang, Chunyan},
  title = {Mitochondria-enriched BMSC exosomes restore microglia–neuron cross-talk in Parkinson’s disease via PINK1/parkin and PI3K/Akt/mTOR pathways},
  journal = {Brain Research},
  year = {2026},
  doi = {10.1016/j.brainres.2026.150487}
}
Kostenlos starten →